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INTRODUCTION 
IN THE past few years, increasing effort has been given to the development of quantit- 
ative methods for the evaluation of neurologic function so that more objective methods 
could take the place of subjective methods in the evaluation of therapeutic response. 
Attempts to estimate the extent and degree of deficits in neurologic function by 
numerical methods have raised questions about the reliability of such scores. Do 
they accurately reflect degrees of neurologic dysfunction? More specifically, can such 
scores be depended upon to portray accurately the changes in degree of a patient’s 
dysfunction from 1 examination to another? Do several examiners, scoring dysfunc- 
tion for the same patient, obtain the same score? It may also be asked whether 
several examiners will observe the same increment of change in a numerical score, 
representing a change in function between successive examinations of the same 
patient. These questions are particularly pertinent in collaborative studies where 
appropriate patient evalution is frequently based on numerical scores and changes 
in scores as obtained at several investigating centers. 
The issues of accuracy and repeatability were particularly relevant to a recent 
cooperative study evaluating ACTH therapy in Multiple Sclerosis [I]. Four different 
methods of evaluating patient dysfunction were used, and the separate items of each 
method were recorded as numerical scores or were changed to numerical scores 
when the items were recorded as “slight”, “moderate”, or “severe”, etc. Since 
patients were evaluated by several investigators who submitted data to one statistical 
center, it was considered essential that a test giving an indication of the reliability 
of the clinical evaluation methods be performed prior to the analysis of the data. 
This report gives the results of the tests of the reliability of 3 of the 4 evaluation 
methods and presents a statistical design that is considered efficient relative to other 
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designs requiring large numbers of cases, and illustrates the use of the design in a 
reliability study. 
METHODS AND MATERIAL 
Three of the 4 methods of evaluating dysfunction were used in this experiment. 
One of these methods was a standard neurologic examination, in which deviations 
from normal were arbitrarily quantified; the second was the numerical scoring system 
for each functional system developed by KURTZKE [2]; and the third was a “‘l-day 
symptom” scoring method that measured both duration and severity of various 
individual symptoms over a week’s period. The fourth method, a battery of quantit- 
ative neurologic tests, was described earlier [3]. The data forms of the 3 methods are 
given in Appendix 1. For a more detailed account of these methods, see the ACTH- 
MULTIPLE SCLEROSIS TUDY PROTOCOL [l J. 
The design of the relability experiment is an incomplete Latin-square, as described 




















































FIG. 1. Roman numerals indicate the sequence of examinations for the multiple 
sclerosis uniformity study-by patient number and examiner. 
(1) There is no difference between the means of the examiners, i.e., on the average, 
examiners obtain uniform scores on the same patient. 
(2) There is no difference between the means of the order of the examinations, i.e., 
the patient’s dysfunction does not change over the period during which the three 
examinations are given. 
(3) There are no differences between the examiner means of the increment change 
(second-first trial), i.e., changes in dysfunctions, as indicated by numerical scores, 
are observed uniformly by different examiners. 
This design appears appropriate in fitting the following restrictions of the experi- 
ments : 
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(a) Patients were not to be examined by more than 3 examiners in a session, to 
minimize the possibility of patient fatigue. 
(b) Only 5 examiners were to be used in the experiment. 
(c) Each examiner was to evaluate an equal number of patients. 
The experiment consisted of 4 parts-2 trials, 6 days apart, each trial including a 
morning and an afternoon session. Five examiners and 5 patients took part in the 
morning session of the first trial. Each examiner evaluated 3 patients in sequence, 
and each patient was examined 3 times. Five different patients were seen in the 
afternoon session, with the same examiners and a similar pattern of testing. Six 
days later the second trial took place with the same examiners, the same schedule, 
and the same patients, except for 1 alternate patient in the morning session. 
Five neurologists from 4 institutions participated in the study-a senior resident 
in neurology and 2 junior and 2 senior clinicians, all experienced in the specific methods 
being used. For this experiment, each of the patients stayed in his assigned room 
and was visited in sequence by 3 examiners. The time needed to perform the tests 
was about 30 min, followed by rest periods for patients of 15-30 min. The completed 
data forms were returned for analysis at the end of each examination, and it was 
requested of the investigators that they not discuss any results until the end of the 
study. When an investigator made his second examination of a given patient 6 days 
later, he could refer to his own first-trial data forms for the patient. This was done 
to aid in determining whether or not the examiners were observing changes in neuro- 
logic function uniformly over the period of 1 week, without having to guess the 
initial level relative to which the second examination was compared. A 6-day interval 
between 2 examinations of any one patient by any examiner was chosen because it 
approximates the l-week interval between examinations that occurs in the cooperative 
study. Since inter-examiner differences in the initial level and in the change between 
the initial and the second trial on a single group of patients were the quantitites to be 
evaluated, the fact that many of the measurements were ordinal, rather than strictly 
numerical, did not violate the assumptions underlying the statistical procedures. 
All of the patients resided in Southern California. Six were males with ages 
ranging from 33 to 51 yr and a median age of 38 yr. The range of ages for the 5 
females was 26-45 yr, with a median of 33 yr. The Kurtzke ratings on the 11 patients 
ranged from 2-7. Only 1 of the patients was considered to be dynamically changing 
at the time of the study. 
An extended Latin-square design was the means of analyzing the sets of data that 
were collected for each of the 4 sessions-morning and afternoon of the first day, 
and morning and afternoon of the second day. The same design was employed 
in the analysis of 2 more sets of data obtained as the differences between results of the 
first trial and results of the second trial. The analysis of variance table utilized in 
this analysis is shown in Appendix II. 
Since a patient’s neurological status might change even in such a short time as 
that between the first and third examinations within any 1 of the sessions, a simul- 
taneous examination by all 5 investigators was considered important, and a special 
session was held. The special session consisted of 3 examinations, during each of 
which, 1 of 3 patients was examined by a senior clinician while the other four neuro- 
logists observed with the exception of some of the neurologic functions such as 
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None of these three patients had taken part in any other session; 2 were females 
with Kurtzke scores of 5 and 6, and one was a male who scored 2. Although the 
conditions of this experiment differed markedly from those at the doctors’ hospitals, 
the experiment provided an opportunity to see how uniformly all 5 of the examiners 
graded the various neurologic dysfunctions. Appendix III shows the analysis of 
variance table for the randomized-blocks design used for the special examinations. 
RESULTS 
Significant differences (p < 0 .Ol) between examiner means for the first week’s 
examination were observed for 14 of the 87 items evaluated. Ten of these items were 
from the neurologic examination, 2 from the neuroIogic status evahtation, and 2 
from the 7-day symptom scoring method. Since each examiner observed a slightly 
different group of patients from that observed by the other examiners, an adjustment 
was made to the examiner means to permit valid comparisons among the 5 examiners. 
The adjusted examiner means and the pairs of examiners for which significant 
difference were found in a multiple range test, as described by STEEL and TORRIE [5], 
are shown in Table 1. These results indicate that most of the differences occurred 
between examiner 1 or examiner 2 and the remaining examiners. Specifically, 
examiner 1 differed from other examiners on the right knee-jerk reflex, supeticial 
sense deficits of legs and trunk, numbness of the right leg, and bowel and bladder 
function, while examiner 2 differed from the others on the left ankle-jerk reflex 
and spasticity of 3 limbs, Other tests of the limbs did not show any such discrepancies 
in reflexes, tone, or sensation. This observation-that each difference is primarily 
between 1 examiner and the others-implies that the others were able to obtain 
reasonably comparable scores. 
For the second week’s examination, significant differences (p ~0.01) between 
examiner means were observed for only 10 of the 87 items. Nine of these were from 
the neurologic examination and I was from the */-day symptom scoring method. 
The adjusted examiner means and the pairs of examiners for which significant 
differences were observed in a muhiple range test are shown in Table 2. These results 
indicate that the significant differences during the second week were primarily 
between pairs of observers rather than between any 1 and the other 4. Examiner 2 
differs from the others on both of the triceps reflexes, and he has the highest score 
for spasticity of the left leg. Examiner 1 differs from the other examiners with respect 
to several measures of sensory deficit. Significant differences during the second week, 
though still attributable to the same 2 examiners as in the first week, were less frequent 
and were mostly attributable to different items. 
A comparison of Table 2 with Table 1 shows that significant differences were 
found for both trials in only 5 specific tests-the superficial sense deficits for the trunk 
and both legs, spasticity for the left leg, and “numbness” for the right leg. Note 
that the other body parts did not show differences for these items. 
To indicate the precision of the tests among the adjusted examiner means, standard 
errors of the means are given in each of the Tables. Note that these standard errors 
are for the discrepant values; those for items without significant differences were 
much smaller. The finding of the few statistically significant differences takes on 
limited importance in view of the additional information that only 5 of the tests 



































































































































































































































































































































































































































































































Evaluating the Status of Multiple Sclerosis Patients 809 
were primarily due to 1 or 2 examiners, and that the differences were observed for 
only a few individual tests rather than for related groups of functions. Furthermore, 
the precision of the methods, as indicated by the small values obtained for the 
standard errors of the means, was high. 
For testing the changes between the first and second trial for the different examiners, 
the results of the first week’s examinations were subtracted from those of the second 
and an adjusted average (n=lO) for the 5 examiners obtained. The only item for 
which a significant difference (p < 0.01) in the average examiner differences occurred 
was the right ankle-jerk reflex, a difference due to examiners 2 and 4. The results of 
the remaining 86 tests were essentially uniform. Such uniformity of the differences 
(second-first trial) among the examiners has particular importance since the differences 
(second-first trial) rather than differences in the level of the functions are used to 
evaluate the efficacy of treatment, notably in the ACTH study. 
From the analysis of examinations with respect to order of examination-the order 
in which each patient’s sequence of 3 took place-only 1 significant difference 
(p < 0.01) was found among the 87 items, that for the bowel and bladder function. 
Interrogation of the patient was the means of obtaining the result of this test. For 
this function, the average score for the second examination was significantly higher 
than those for the first and third tests. 
The analysis of the results of the 3 special examinations, in which all 5 examiners 
participated simultaneously, showed that there were no significant differences 
(p < 0.01) in examiner means for any of the neurologic functions tested. 
The observation of very few statistically significant differences in this entire study 
takes on added importance in view of the facts that only 5 of the items gave any 
significant differences at both the tist week’s and the second week’s trials, that these 
differences were primarily due to 1 or 2 examiners, that only 1 item out of 87 showed 
a significant difference in the degree of change between the 2 examinations, and that 
there were no significant examiner differences for the special examinations. 
DISCUSSION 
The assessment of treatment results in multiple sclerosis presents various problems. 
To be useful in demonstrating statistically significant trends or differences, assessment 
methods must be shown to be reliable. The results of this study-that the 5 examiners 
did not differ significantly in 82 of the 87 items included in the 3 scoring methods- 
indicate that the methods evaluated can be used in obtaining appropriate data on 
neurological dysfunction and on changes of function in multiple sclerosis patients. 
Some of the significant differences that were observed may have been due to chance 
as they appeared sporadically-such as reflexes on one side but not the other- 
and were not present on repeated testing. Significant differences were observed for 
only 1 or 2 of the 5 examiners on even these deviant items. Most importantly, although 
differences in the level of a neurologic function occurred on several items, differences 
between examiners did not occur when the results of the first week’s tests were 
compared to those of the second week. This indicates that even if different examiners 
tend to observe several functions at different levels, they do appear to observe changes 
in neurologic function uniformly. And it is this reliability in the evaluation of 
increment change that is most pertinent to the conduct of a therapeutic trial. 
This study illustrates the use of an efficient statistical design, which can be used 
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to test whether or not results from various investigators in a cooperative trial can 
be pooled for valid analysis. The incomplete Latin-square design used in this study 
required only 2 x 5 x 3=30 observations, whereas, a comparable 3-factor analysis 
of variance design would have required 10 x 5 x 3= 150 observations. A test of the 
hypothesis that there is no difference in the order of examinations gave support to 
the assumption that a sequence of 3 examinations would not significantly alter a 
patient’s neurologic functions. The finding of the test was that there were no signifi- 
cant differences in the sequences of the 3 examinations except for one of the 87 items 
measured, and even here, it was the second exam that differed from the other 2. 
Since each patient was examined only 3 times instead of 5-a precaution taken to 
minimize the effects of fatigue on repeated assessment of the neurologic function of a 
single patient-the 5 x 3 Latin-square design is classed as incomplete. 
Utilizing such a design it is possible to obtain information on the uniformity of 
pooled data and to make statements regarding the reliability of the data for the 
various neurologic functions. Specifically, for this ACTH study it will be possible to 
indicate the variables for which statistical analysis should be meaningful. When 
such precautions are included in the design and analysis of data, unwarranted infer- 
ences will be minimized and progress in the evaluation of such chronic diseases as 
multiple sclerosis may continue. 
SUMMARY 
The reliability of three different evaluation methods used in a cooperative clinical 
trial of the efficacy of ACTH in multiple sclerosis patients was evaluated in a uni- 
formity study that used an efficient statistical design requiring only 10 patients and 
5 examiners. The methods were the standard neurologic examination, a scoring 
system for functional grades and disability status, and a ‘I-day symptom score. Each 
patient was examined only 3 times at the beginning of the study and 3 more times 
6 days later, No significant differences among the 5 examiners were observed on 82 
of the 87 items used to measure neurologic function. With the exception of 1 variable, 
there were no significant differences among the average values of the sequence of the 
3 examinations, nor among the average increments of change in the numerical 
scores between the first and second trials. 
In an additional examination in which all 5 examiners simultaneously evaluated 
3 patients 1 at a time, it was found that the 5 examiners observed uniformly in all 
of the neurologic tests. 
The results of this study indicate that, by and large, the three evaluation methods 
appear to be reliable in the evaluation of neurologic status when used in a cooperative 
clinical trial where several investigators contribute data. Furthermore, investigations 
of reliability in cooperative studies can be performed with the use of efficient statis- 
tical designs such as the incomplete Latin-square design. 
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A. Neurobgic examination 
APPENDIX I 
1. Vision: Acuity, R and L (Snellen Chart) 
Field Abnormalities, R and L, Yes or No 
2. Reflexes: (O-5+, 2+: average) 
Biceps, R and L Plantar; Extensor, R and L 
Triceps, R and L Neutral, R and L 
Radial, R and L Flexor, R and L 
Kneejerk, R and L Snout; present, Yes or No 
Ankle-jerk, R and L Jaw; abnormal, Yes or No 
Abdominals; present, R and L, Yes or No 
3. Brain Stem-Signs of Abnormalities: 
(O=none, 1 =slight, 2=moderate, 3=severe, 4=total) 
Facial weakness Dysarthria 
Facial sensory loss Dysphagia 
Nystagmus Other bulbar signs 
EOM and/or gaze impairment 
4. Limb Weakness : 
(O=none, 1 =slight, 2=moderate, 3=severe, 4=total) 
RU, RL, LU, LL 
5. Limb Spa&city: 
(O=none, 1 =slight, 2=moderate, 3=severe, 4==total) 
RU, RL, LU, LL 
6. Limb Coordination Impairment: 
(O=none, 1 =slight, 2=moderate, 3=severe, 4=total) 
RU, RL, LU, LL 
7. Sensory Deficit : 
(O=none, 1 =slight, 2=moderate, 3=severe, 4=total) 
Vibratory; RU, RL, LU, LL 
Position; RU, RL, LU, LL 
Superficial; RU, RL, LU, LL. Tnmk 
8. Gait Impairment : 
(O=none, 1 =slight, 2=moderate, 3 =severe, 4=total) 
9. 
10. 
Other: (O=none, 1 =slight, 2=moderate, 3=severe, 4=total) 
Mental Status: 
(O=none, 1 =shght, 2=moderate, 3=severe, 4=total) 




Intellect Impairment __ _.___ 
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B. Neurologic Status Evaluation 
1. Pyramidal functions: 
O=normal 
1 =abnormal signs-without disability 
2=miminal disability 
3 =mild or moderate paraparesis or hemiparesis; severe monoparesis 
4=marked paraparesis or hemiparesis, moderate quadriparesis; or monoplegia 
5 =paraplegia, hemiplegia, or marked quadriparesis 
6=quadriplegia 
2. Cerebellar functions: 
O=normal 
1 =abnormal signs without disability 
2=mild ataxia 
3=moderate truncal or limb ataxia 
4=severe ataxia all limbs 
5=unable to perform coordinated movements due to ataxia 
3. Brain stem functions : 
O=normal 
1 = signs only 
2 =moderate nystagmus or other mild disability 
3 =severe nystagmus, marked extraocular weakness, or moderate disability of other 
cranial nerves 
4=marked dysarthria or other marked disability 
5=inability to swallow or speak 
4. Sensory functions: 
O=normal 
1 =vibration or figure-writing decrease only l-2 limbs 
2=vibration decrease 3-I limbs, or position or discrimination decrease l-2 limbs 
3=mild decrease touch, pain; or loss position, vibration l-2 limbs 
4=moderate decrease touch, pain for at least most of 1 limb; severe propriocep- 
tive decrease 3-4 limbs 
5=loss of sensation for 1 limb, or moderate decrease touch, pain of most of body 
6=analgesia and anesthesia to neck 
5. Bowel and Bladder functions: 
O=normal 
1 =miId hesitancy, urgency, or retention 
2=moderate hesitancy, urgency, retention, or rare urinary incontinence 
3 =frequent incontinence 
4=in need or almost constant catheterization but with adequate bowel function 
5 =loss of bowel and bladder function 
6. Visual functions: 
0 =normal 
1 =scotoma with visual acuity (corrected) better than 20/30 
2=worse eye with scotoma with maximal visual acuity (corrected) of 20159 
3 =worse eye with large scotoma, or moderate decrease h fields, but with maximal 
visual acuity (corrected) of 20/60 to 20/99 
4=worse eye with marked decrease of fields and maximal visual acuity (corrected) 
of 20/100 to 20/200; grade 3 plus maximal acuity of better eye 20/60 or less 
5 aworse eye with maximal visual acuity (corrected) less than 2O@IO; grade 4 plus 
maximal acuity of better eye 20/60 or less 
6=grade 5 plus maximal visual acuity of better eye 20/60 or less 
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7. Mental functions 
O=-normal 
1 -mood alternation only 
2=mild decrease mentation 
3 -moderate decrease mentation 
4=marked decrease mentation (chronic brain syndrome, moderate) 
5 =dementia; or chronic brain syndrome, severe, incompetent 
8. Other functions: 
O-none 
1 ‘any other findings (specify) 
9. Disability Status Scale in Multiple Sclerosis: 
O=normal neurologic exam (all grade 0 in functional systems) 
1 =no disability, minimal signs 
2=minimal disability 
3 =moderate disability though fully ambulatory 
4=relatively severe disability though fully ambulatory and able to be self-sufficient 
and up and about for some 12 hr a day 
5=disability severe enough to preclude ability to work a full day without special 
provisions; maximal motor function walking unaided no more than several 
blocks 
6=assistance required for walking 
‘I=restricted to wheel chair-able to wheel self and enter and leave chair alone 
8=restricted to bed but with effective use of arms 
9=totally helpless bed patients 
lO=death due to multiple sclerosis 
C. Seven-day symptom scoring 
r Number of days bf severity &ring last 7 days 1 
1. Extremity Symptoms Slight I 
Is symptom part of 
M;dzr:te 
I Severe current bout ? 
Ixd -!- j- 3xd* Yes No 
Number of days of R. arm , 
weakness or L. arm 
incordination or R. leg 
cerebellar ataxia L. leg 
during last 7 days 
I I 
I I 
* d= number of days 
paresthesias &ring R. leg 
last 7 days L. leg 
2. Visual Symptoms 
Number of days of R.eye 
impaired vision due L.eye 
to retrobulbar 
neuritis during the 
last 7 days 
Gait ataxia 
Girdle sense 
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APPENDIX II 






























Calculate the column totals C,, the block totals B,, the treatment totals T,, the replicate 
totals R,, and the grand total G. 
(a) For replicate sum of squares R-‘&s G= - - - - 
rt rb 
(b) For column sum of squares 
CC,z G= 
C= b - - 
rb 
(c) For order sum of squares O=C-R 
For treatment sum of squares (unadjusted) 
L;Tha Ga 
T= 7 - - 
rb 
Compute for each treatment the quantity Q,=KT,-Bt,, where Bt,=total for all blocks 
in which treatment tlr appears, and K is the number of times a patient is examined, For 
treatment sum of squares (adjusted) T,= -&Qf, where t is the number of treatments, 
and A is the number of times that each pair of examiners occurs together. 
ZB; G* 
For block sum of squares (unadjusted) B,= b - rb and for block sum of equares 
(adjusted) B=B,+T,-T. 
For error sum of squares E= i g Xit-(Ci-B+T). 
I i 
APPENDIX III 









Total rc-1=14 i Efy*j-Ty 
i=lj=l 
